Skip to main content
. 2020 Aug 17;17(4):849–855. doi: 10.5114/aoms.2020.98167

Table II.

Medication prior to stenting

Medication Unmatched cohort Matched cohort
Double-vessel disease (n = 244 patients) Single-vessel disease (n = 355 patients) P-value Double-vessel disease (n = 226 patients) Single-vessel disease (n = 226 patients) P-value
Aspirin 85% 83% 0.579 85% 82% 0.525
Clopidogrel 39% 42% 0.454 40% 42% 0.848
Statin 76% 80% 0.370 76% 81% 0.252
ACE inhibitor 73% 74% 0.926 74% 78% 0.379
Beta-blocker 60% 62% 0.673 60% 57% 0.633